Vitamin D levels and bone turnover markers are not related to non-alcoholic fatty liver disease in severely obese patients;Los niveles de vitamina D y ma rcado res de recam bio oseo no se encuent ran relacionados con el hígado graso no alc óholico en obesos mórbidos

Nutricion Hospitalaria

Volumn 30, Issue 6, 2014, Pages 1256-1262

  Rodríguez, Rubén Díez ^a   Pomar, María D Ballesteros ^a   Fernández, Alicia Calleja ^a   Antolin, Sara Calleja ^a   Rodríguez, Isidoro Cano ^a   Torres, Pedro Linares ^a   Plaza, Francisco Jorquera ^a   Goñi, José Luis Olcoz ^a  

^a Complejo Asistencial Universitario de León   (Spain)

Author keywords

Morbid obesity; Non alcoholic fatty liver Disease; Vitamin d deficiency

Indexed keywords

BIOLOGICAL MARKER; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

ADULT; BONE DENSITY; BONE REMODELING; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MORBID OBESITY; NONALCOHOLIC FATTY LIVER;

ADULT; BIOMARKERS; BONE DENSITY; BONE REMODELING; FEMALE; HUMANS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY, MORBID; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

EID: 84913606267     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.30.6.7948     Document Type: Article

References (35)

1. Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovasc Diabetol 2009;8:7.
2. Kendrick J, Targher G, Smits G, Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009;205(1):255-60.
3. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. The American journal of cardiology 2010;106(7):963-8.
4. Targher G, Byrne CD. Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link? Endocrine 2014.
5. Gonzalez-Molero I, Rojo-Martinez G, Morcillo S, Gutierrez C, Rubio E, Perez-Valero V, et al. Hypovitaminosis D and incidence of obesity: a prospective study. European journal of clinical nutrition 2013;67(6):680-2.
6. Ybarra J, Sanchez-Hernandez J, Gich I, De Leiva A, Rius X, Rodriguez-Espinosa J, et al. Unchanged hypovitaminosis D and secondary hyperparathyroidism in morbid obesity after bariatric surgery. Obesity surgery 2005;15(3):330-5.
7. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. The American journal of clinical nutrition 2000;72(3):690-3.
8. Earthman CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond). 2012;36(3):387-96.
9. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012;142(7):1592-609.
10. Ballesteros Pomar M, Urioste Fondo A, Gonzázez de Francisco T, Olcoz Goñi J, González Herraez L, Bailador C, et al. Prevalence and predictors of Non-Alcoholic Fatty liver Disease (NAFLD) in morbidly obese patients undergoing bariatric surgery. Int J Obes (Lond). 2007(31):S133.
11. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011;34(3):274-85.
12. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010;52(5):1836-46.
13. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, Morini S, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC medicine 2011;9:85.
14. Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013;38(3):246-54.
15. Salas-Salvado J, Rubio MA, Barbany M, Moreno B. SEEDO 2007 Consensus for the evaluation of overweight and obesity and the establishment of therapeutic intervention criteria. Medicina clinica 2007;128(5):184-96; quiz 1 p following 200.
16. Executive summary: Standards of medical care in diabetes--2013. Diabetes Care 2013;36 Suppl 1:S4-10.
17. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA: the journal of the American Medical Association 2001;285(19):2486-97.
18. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. The Journal of clinical endocrinology and metabolism 2011;96(7):1911-30.
19. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39(2):239-44.
20. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313-21.
21. Li L, Zhang L, Pan S, Wu X, Yin X. No significant association between vitamin D and nonalcoholic fatty liver disease in a Chinese population. Digestive diseases and sciences 2013;58(8):2376-82.
22. Katz K, Brar PC, Parekh N, Liu YH, Weitzman M. Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. Journal of obesity 2010;2010:496829.
23. Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 2012;55(4):1103-11.
24. Nakano T, Cheng YF, Lai CY, Hsu LW, Chang YC, Deng JY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol 2011;55(2):415-25.
25. Sharifi N, Amani R, Hajiani E, Cheraghian B. Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial. Endocrine 2014.
26. Aller R, Castrillon JL, de Luis DA, Conde R, Izaola O, Sagrado MG, et al. Relation of osteocalcin with insulin resistance and histopathological changes of non alcoholic fatty liver disease. Annals of hepatology 2011;10(1):50-5.
27. Pietschmann P, Resch H, Muller C, Woloszczuk W, Willvonseder R. Decreased serum osteocalcin levels in patients with liver cirrhosis. Bone and mineral 1990;8(2):103-8.
28. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130(3):456-69.
29. Reis JP, von Muhlen D, Kritz-Silverstein D, Wingard DL, Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007;30(6):1549-55.
30. Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, Tsai GP, et al. Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism: clinical and experimental 2000;49(11):1501-5.
31. Lee DM, Rutter MK, O’Neill TW, Boonen S, Vanderschueren D, Bouillon R, et al. Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. European journal of endocrinology/European Federation of Endocrine Societies. 2009;161(6):947-54.
32. Kayaniyil S, Vieth R, Harris SB, Retnakaran R, Knight JA, Gerstein HC, et al. Association of 25(OH)D and PTH with metabolic syndrome and its traditional and nontraditional components. The Journal of clinical endocrinology and metabolism 2011;96(1):168-75.
33. Minambres I, de Leiva A, Perez A. Hypovitaminosis D and metabolic syndrome. Medicina clinica 2014. http://dx.doi.org/10.1016/j.medcli.2013.12.012
34. Moreiro J, Ruiz O, Perez G, Salinas R, Urgeles JR, Riesco M, et al. Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion. Obesity surgery 2007;17(3):348-54.
35. Alvarez V, Cuevas A, Olivos C, Berry M, Farias MM. Micronutrient deficiencies one year after sleeve gastrectomy. Nutricion hospitalaria 2014;29(1):73-9.